中國供應鏈產業(03708.HK)與大運亨通集團訂立戰略合作框架協議
格隆匯12月10日丨中國供應鏈產業(03708.HK)發佈公吿,2021年12月9日,公司與安徽大運亨通電子商務股份有限公司(“大運亨通集團”)訂立無法律約束力的戰略合作框架協議,內容有關就大健康農業食品及相關產品領域的潛在合作。
根據戰略合作框架協議,集團及大運亨通集團旨在共同打造、優化及升級大健康農業食品的產業鏈管理平台,該平台可透過OTO線上線下系統為企業提供一站式供應鏈管理服務,助力企業接觸上游供應商及下游客户,並提升相關產品的銷售及分銷。戰略合作框架協議的年期自戰略合作框架協議日期起計為期三年,可由一方向另一方發出三個月的事先書面通知予以終止。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.